| 1 |
Cotton PB, Eisen GM, Aabakken L，et al.A lexicon for endoscopic adverse events：report of an ASGE workshop[J]．Gastrointest Endosc，2010，71：446-454.
|
| 2 |
Dumonceau JM, Kapral C, Aabakken L，et al.ERCP-related adverse events：European Society of Gastrointestinal Endoscopy(ESGE)Guideline[J]．Endoscopy，2020，52(2)：127-149.
|
| 3 |
Shan-Shan, Liu, Xiao-Hua，et al.Risks of Postendoscopic Retrograde Cholangiopancreatography Pancreatitis and Hyperamylasemia After Endoscopic Papillary Balloon Dilation：A Retrospective Analysis[J]．Surg Laparosc Endosc Percutan Tech, 2019，29(4)：280-284.
|
| 4 |
Kato K, Shiba M, Kakiya Y，et al.Celecoxib Oral Administration for Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis：A Randomized Prospective Trial[J]．Pancreas，2017，46(7)：880.
|
| 5 |
Elmunzer BJ, Waljee AK, Elta GH，et al.A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis[J]．Gut，2008，57：1262-1267.
|
| 6 |
Pekgöz M．Post-endoscopic retrograde cholangiopancreatography pancreatitis：A systematic review for prevention and treatment[J]．World J Gastroenterol，2019，25(29)：4019-4042.
|
| 7 |
Tryliskyy Y, Bryce GJ.Post-ERCP pancreatitis：Pathophysiology，early identification and risk stratification[J]．Adv Clin Exp Med，2018，27(1)：149-154.
|
| 8 |
Engel C．European Society of Gastrointestinal Endoscopy(ESGE)Guideline：Prophylaxis of post-ERCP pancreatitis[J]．Endoscopy，2010，42(6)：503-515.
|
| 9 |
中华医学会消化内镜学分会ERCP学组，中国医师协会消化医师分会胆胰学组，国家消化系统疾病临床医学研究中心．中国ERCP指南(2018版)[J]．中华消化内镜杂志，2018，35(11)：777-813.
|
| 10 |
Eling TE, Baek SJ, Shim M，et al.NSAID activated gene(NAG-1)，a modulator of tumorigenesis[J]．J Biochem Mol Biol，2006，39(6)：649-655.
|
| 11 |
Wagh MS, Sherman S．Indomethacin for Post-ERCP Pancreatitis Prophylaxis：Another Attempt at the Holy Grail[J]．Am J Gastroenterol，2007，102(5)：984-986.
|
| 12 |
Chi-Huan, Wu NJ, Liu CN，et al.Predicting cholecystocholedochal fistulas in patients with Mirizzi syndrome undergoing endoscopic retrograde cholangiopancreatography[J]．World J Gastroenterology，2020，26(40)：6241-6249.
|
| 13 |
Serrano J, Moura DD, Bernardo W，et al.Nonsteroidal anti-inflammatory drugs versus placebo for post-endoscopic retrograde cholangiopancreatography pancreatitis：a systematic review and meta-analysis[J]．Endosc Int Open，2019，7(4)：E477-E486.
|
| 14 |
Yang J, Wang W, Liu C, et al.Rectal Nonsteroidal Anti-Inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention：A Network Meta-Analysis[J]．J Clin Gastroenterol，2020，54(4)：305-313.
|
| 15 |
Kalantzis I, Poulou A, Papatheodorou A，et al.Rectal versus intramuscular diclofenac in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis：experience of a Greek tertiary referral center[J]．Ann Gastroenterol，2020，33(4)：412-417.
|
| 16 |
赵孝文，鲍峻峻，胡翠，等．双氯芬酸钠预防经内镜逆行胰胆管造影术后胰腺炎机制的临床研究[J]．中华消化内镜杂志，2014，31(10)：575-578.
|
| 17 |
Khoshbaten M, Khorram H, Madad L，et al.Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis[J]．J GastroenterolHepatol，2010，23(7 Pt 2)：e11-e16.
|
| 18 |
Lee HJ, Cho CM, Heo J，et al.Impact of Hospital Volume and the Experience of the Endoscopist on Adverse Events Related to Endoscopic Retrograde Cholangiopancreatography：A Prospective Observational Study[J]．GutLiver，2020，14(2)：257-264.
|
| 19 |
Stefanelli Paola, Teloni Raffaela, Carannante Anna, et al.Neisseria gonorrhoeae triggers the PGE2/IL-23 pathway and promotes IL-17 production by human memory T cells[J]．Prostaglandins Other Lipid Mediat，2012，99(1/2)：24-29.
|
| 20 |
蓝升红，周丽萍，屠金夫，等．前列腺素E2对重症胰腺炎大鼠血清肿瘤坏死因子及白介素-6的调控作用[J]．肝胆胰外科杂志，2001，13(2)：67-69.
|